Bruker (NASDAQ:BRKR – Get Free Report) updated its FY 2024 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 2.590-2.640 for the period, compared to the consensus estimate of 2.640. The company issued revenue guidance of $3.4 billion-$3.4 billion, compared to the consensus revenue estimate of $3.4 billion. Bruker also updated its FY24 guidance to $2.59-2.64 EPS.
Analyst Upgrades and Downgrades
Several research firms have recently issued reports on BRKR. The Goldman Sachs Group decreased their price target on Bruker from $72.00 to $60.00 and set a sell rating for the company in a research report on Tuesday, July 9th. Citigroup lowered their target price on Bruker from $95.00 to $80.00 and set a buy rating on the stock in a research note on Wednesday, July 10th. Jefferies Financial Group assumed coverage on shares of Bruker in a research report on Monday, June 3rd. They set a buy rating and a $85.00 price target for the company. TD Cowen lowered their price objective on shares of Bruker from $74.00 to $72.00 and set a hold rating on the stock in a research report on Wednesday. Finally, StockNews.com downgraded shares of Bruker from a buy rating to a hold rating in a research report on Tuesday, May 21st. One research analyst has rated the stock with a sell rating, four have issued a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, Bruker has an average rating of Hold and an average target price of $80.80.
Check Out Our Latest Stock Report on Bruker
Bruker Price Performance
Bruker (NASDAQ:BRKR – Get Free Report) last released its quarterly earnings results on Tuesday, August 6th. The medical research company reported $0.52 EPS for the quarter, hitting analysts’ consensus estimates of $0.52. The business had revenue of $800.70 million during the quarter, compared to analysts’ expectations of $799.44 million. Bruker had a net margin of 13.38% and a return on equity of 27.31%. The business’s quarterly revenue was up 17.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.50 EPS. Analysts expect that Bruker will post 2.66 EPS for the current fiscal year.
Bruker Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Monday, June 17th. Shareholders of record on Monday, June 3rd were paid a $0.05 dividend. This represents a $0.20 annualized dividend and a yield of 0.32%. The ex-dividend date of this dividend was Monday, June 3rd. Bruker’s dividend payout ratio is currently 7.27%.
Bruker Company Profile
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.
See Also
- Five stocks we like better than Bruker
- How to Choose Top Rated Stocks
- The Cannabis Sector: Profitability Takes Center Stage
- Energy and Oil Stocks Explained
- Amazon’s Stock Plunge: Is a Prime Buying Opportunity Knocking?
- What is the Hang Seng index?
- Buy the Dip in e.l.f. Beauty: Analysts Point to a New High
Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.